Skip to main content
ESPR filings

Corporate insider profile

Sheldon L. Koenig Filing Activity

Latest reported as President and CEO of Esperion Therapeutics, Inc. (ESPR).

Purchase filings
0
Reported companies
1
Net open-market value
-$169,070.14
Latest transaction
Jun 17, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 17, 2026Esperion Therapeutics, Inc. (ESPR)President and CEOSale53,588$3.16$169,070